Skip to main content

How to Digitalise Your Pharmacy: A Practical Roadmap for 2026

Most German pharmacy owners know they need to digitalise. The question is not whether — it is what to build first, in what order, and how to avoid spending money on tools that don't talk to each other.

According to the APOkix pharmacy industry index (IFH Köln, April 2025), 86% of German pharmacy owners agree that without digital tools, staying competitive will become increasingly difficult. Yet 49% rate their own pharmacy's digitalisation level as only average, and 5% describe it as minimal or not started. The gap is not a lack of intention — it is a lack of a clear implementation sequence.

This roadmap gives you that sequence. It is built around four phases — Foundation, Patient Interface, Reach and Retention, and Intelligence — each with a clear objective, the tools required, and the order of operations that makes each phase work. It links to the detailed guides for each individual tool so you can go deep on any component when you're ready.

The single most common digitalisation mistake in German pharmacies:investing in a patient-facing app before the E-Rezept workflow is stable. Patients who encounter broken digital prescription experiences don't try again. Sequence matters more than speed.

The Four-Phase Roadmap at a Glance

PhaseTimelineWhat You're BuildingCore Tools
1 — FoundationMonths 1–2E-Rezept compliance + AVS readinessAVS, gematik connector, E-Rezept workflow
2 — Patient InterfaceMonths 2–4Branded pharmacy app + Click & CollectPharmacy app platform, online ordering
3 — Reach & RetentionMonths 3–6Botendienst integration + digital commsDelivery workflow, push notifications, loyalty
4 — IntelligenceMonth 6+AI chatbot + ePA readiness + data insightAI assistant, ePA connector, analytics

Phase 1: Foundation (Months 1–2)

Before anything patient-facing, your back-end infrastructure must be solid. The foundation of every digital pharmacy in Germany is E-Rezept readiness — and in 2026, readiness means more than basic compliance.

E-Rezept: Beyond compliance into workflow

The E-Rezept has been mandatory since early 2024. But there is a wide gap between pharmacies that process E-Rezepte reactively (when patients present them) and pharmacies that use E-Rezept as the starting point for a digital patient relationship. The goal of Phase 1 is to move from the former to the latter. At the end of Phase 1, your pharmacy should be able to: receive E-Rezepte forwarded via app before the patient arrives, process them in your AVS without manual re-entry, provide patients with real-time status updates, and have the infrastructure in place to add Click & Collect in Phase 2 without rework.

AVS integration: The layer everything depends on

Your Apothekenverwaltungssystem (AVS) is the backbone of your digital operations. Every patient-facing tool — app, Click & Collect, Botendienst, chatbot — only works if it integrates cleanly with your AVS. Before adding any patient-facing layer, confirm your AVS version supports the integrations you're planning, that your E-Rezept connector is fully configured, and that incoming digital orders appear in the AVS workflow without manual intervention.

GDPR baseline

Any digital tool that handles patient data — which is all of them — requires a compliant GDPR foundation. At minimum: an Art. 28 data processing agreement with each software provider, a privacy policy that covers digital data collection, and clarity on your legal basis for processing health data.

E-Rezept receiving via app + eGK + CardLink configured
AVS integration confirmed with incoming order queue
GDPR/Art. 28 agreements with all digital providers
Staff trained on digital prescription workflow

Phase 2: Patient Interface (Months 2–4)

With a stable E-Rezept and AVS foundation, you can now build the patient-facing layer. This is where your pharmacy becomes visible and usable to patients on their phones.

Your branded pharmacy app

A branded pharmacy app — as opposed to being listed on an aggregator platform — gives you a direct, owned digital relationship with your patients. According to APOkix data, 51% of German pharmacies now have an app; 74% list on aggregator platforms. The difference matters: on an aggregator, you are one option among many, competing on price. In your own app, you are the pharmacy. Your app should, at minimum, enable E-Rezept forwarding, show real-time product availability, allow Click & Collect ordering, and send push notifications for order status updates.

Click & Collect: The highest-ROI first digital service

Click & Collect is the entry point for most pharmacy digital journeys — patients order online, collect in-store. It is low operational complexity (no delivery logistics), high patient convenience, and creates a natural E-Rezept integration: the patient forwards the prescription, you prepare it, they collect when ready. The implementation requirement: orders placed via app or website must flow directly into your AVS queue, trigger a preparation workflow, and send an automated "ready for collection" notification to the patient.

Branded pharmacy app live with E-Rezept forwarding
Click & Collect connected end-to-end (app → AVS → notification)
Patient onboarding communications sent
In-store signage and staff briefing done

Phase 3: Reach and Retention (Months 3–6)

Phase 3 is where digital tools stop being a convenience feature and start being a retention strategy. The goal: create patient relationships that are functionally frictionless — so switching to a competitor requires active effort.

Botendienst: Home delivery as retention

84% of German pharmacies offer some form of Botendienst — but most run it informally, without digital integration, without a systematic pricing policy, and without using it strategically. A properly integrated Botendienst — ordered through your app, tracked via notification, priced correctly (€2.50 Rx fee via PZN 06461110; OTC-only deliveries priced separately) — turns delivery into a habit-forming patient touchpoint.

Digital communications and push notifications

A pharmacy app that doesn't communicate is a missed opportunity. Push notifications — used correctly — are the highest-engagement digital channel available to pharmacies. Order-ready notifications, repeat prescription reminders, seasonal health information, opening hours changes. The key discipline: relevance. Patients tolerate notifications that are useful and timely. They uninstall apps that send generic promotional content.

Aggregator presence alongside your branded app

Being on platforms like ihreapotheken.de or gesund.de (74% of pharmacies do this) is not in conflict with having your own branded app — they serve different patient acquisition functions. Aggregators bring discovery; your app builds loyalty. The sequencing is: use aggregators for new patient acquisition, then migrate engaged patients to your branded app.

Botendienst digital ordering live in app
Botendienst fee billing configured correctly in AVS (PZN 06461110 for Rx only)
Push notification strategy defined by patient segment
Aggregator listings updated with current services

Phase 4: Intelligence (Month 6 and Beyond)

Phase 4 is where your pharmacy's digital infrastructure starts generating information — and where AI tools begin to add meaningful value. This phase requires Phases 1–3 to be stable before it delivers results.

AI chatbot: Automating the front desk

With a functioning digital patient relationship established, an AI chatbot can take over routine inbound enquiries — opening hours, order status, E-Rezept guidance, Click & Collect and Botendienst requests, OTC product information — freeing pharmacist time for complex patient interactions. The legal boundary is non-negotiable: a pharmacy AI chatbot operates as a limited-risk AI system under the EU AI Act. It provides information and workflow support. It does not replace pharmaceutical consultation (Beratungspflicht under §20 ApBetrO).

ePA readiness

The elektronische Patientenakte (ePA) is live for patients who have opted in, with the electronic medication plan (eMP) rolling out as a structured layer within it. For pharmacies, ePA readiness in 2026 means: your AVS can read and write to the ePA medication plan, your staff understand the opt-out process for automatic E-Rezept copy to the ePA, and you have patient communication in place. One deadline that is already past: the RSA-to-ECC migration for TI connector cards (SMC-B and HBA) was required by December 31, 2025. If your pharmacy has not yet completed this migration, it is urgent.

Data and performance insight

By Phase 4, your digital channels are generating data: app downloads, order volumes, Click & Collect vs Botendienst split, notification open rates, chatbot query categories. This data tells you which services your patients actually use, which patient segments are most engaged, and where to invest next.

AI chatbot live with escalation paths configured
ePA medication plan integration confirmed with AVS
PoPP timeline tracked with your gematik connector provider
Digital channel performance reviewed monthly

Six Digitalisation Mistakes German Pharmacies Make (and How to Avoid Them)

Common MistakeWhy It Stalls Digitalisation
Starting with the app before E-Rezept is stablePatients encounter broken E-Rezept workflows inside the app, lose trust, and stop using it. Fix the backend first.
Choosing a platform that doesn't integrate with your AVSEvery order creates manual double-entry work for staff, eliminating the efficiency gain and creating dispensing errors.
Going live with Click & Collect but not telling patientsDigital tools only create value when patients use them. Launch without communication = low adoption, abandoned investment.
Charging the €2.50 Botendienst fee for OTC deliveriesThis is a billing error with retaxation risk. The statutory fee applies to Rx only. OTC delivery must be priced separately.
Using a general-purpose AI tool for patient queriesGeneral AI tools are not GDPR-compliant for health data, not scoped for Beratungspflicht limits, and create liability exposure.
Treating digitalisation as a one-time projectE-Rezept, ePA, PoPP, and AI Act requirements are all evolving. Build a system you update — not one you install and forget.

How Mediloon Supports Each Phase

Disclosure: This guide is published by Mediloon. Mediloon is a Leipzig-based platform built for German pharmacies that covers Phases 2–4 of this roadmap in a single, AVS-integrated subscription at €199/month. The platform includes: a branded pharmacy app with E-Rezept forwarding (Phase 2), Click & Collect and Botendienst ordering with push notifications (Phases 2–3), and the Medi AI assistant for patient-facing automation (Phase 4). Mediloon integrates with the major AVS systems — meaning Phase 1 (your existing AVS setup) is the foundation we build on, not something we replace. If you are at Phase 1 and want to understand how the subsequent phases would work together, we are happy to walk through it.

Frequently Asked Questions

Where should a pharmacy start with digitalisation in 2026?

Start with E-Rezept. Not because it is the most exciting digital service — it isn't — but because it is the foundation everything else depends on. A pharmacy app that forwards E-Rezepte which then break in your AVS damages patient trust and undermines every subsequent digital investment.

How long does full pharmacy digitalisation take?

A realistic timeline for a pharmacy going from minimal digital infrastructure to a fully integrated setup (app, Click & Collect, Botendienst, AI chatbot) is six to nine months, assuming you are working with a platform that integrates with your existing AVS.

Do patients in Germany actually use pharmacy apps?

Yes — and adoption is growing. APOkix data shows 51% of German pharmacies now have an app, and digital pre-ordering (for both Click & Collect and Botendienst) is offered by 89% and 84% of pharmacies respectively. The demand is there.

What is the biggest compliance risk in pharmacy digitalisation?

Two risks dominate. First: GDPR non-compliance — specifically, using software platforms without Art. 28 data processing agreements in place. Second: Botendienst fee billing errors — charging the €2.50 statutory fee for OTC-only deliveries, which creates retaxation risk.

Is it worth digitalising if my pharmacy is small or single-location?

Yes — the ROI case for small pharmacies is arguably stronger, not weaker. A single-location pharmacy that loses patients to an online competitor loses a proportionally larger share of its revenue. Digital services reduce the pull of online competitors by matching their core convenience advantage at the local level.

About Mediloon

Mediloon is a Leipzig-based healthtech company building digital infrastructure for German pharmacies — including E-Rezept integration, pharmacy apps, Click & Collect, Botendienst coordination, and the Medi AI assistant. This article is part of Mediloon's pharmacy digitalisation guide series. It is intended as general operational and regulatory information. For specific legal or compliance queries relating to AI systems in your pharmacy, consult your regional Apothekerkammer or a qualified legal advisor.